Cargando…
MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
BACKGROUND: To investigate the expression of MMP-14 and CD44 as well as epithelial-to-mesenchymal transition(EMT)-like changes in ovarian cancer and to determine correlations with clinical outcome. METHODS: In 97 patients with ovarian cancer, MMP-14 and CD44 expression as determined by immunohistoch...
Autores principales: | Vos, Maria Caroline, Hollemans, Eva, Ezendam, Nicole, Feijen, Harry, Boll, Dorry, Pijlman, Brenda, van der Putten, Hans, Klinkhamer, Paul, van Kuppevelt, Toin H., van der Wurff, Anneke A. M., Massuger, Leon F. A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010680/ https://www.ncbi.nlm.nih.gov/pubmed/27590006 http://dx.doi.org/10.1186/s13048-016-0262-7 |
Ejemplares similares
-
Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer
por: Vos, M. Caroline, et al.
Publicado: (2016) -
The role of MMP-14 in ovarian cancer: a systematic review
por: Vos, M. Caroline, et al.
Publicado: (2021) -
Immunohistochemical expression of MMP-14 and MMP-2, and MMP-2 activity during human ovarian follicular development
por: Vos, Maria Caroline, et al.
Publicado: (2014) -
Drug delivery systems for ovarian cancer treatment: a systematic review and meta-analysis of animal studies
por: Raavé, René, et al.
Publicado: (2015) -
Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study
por: Reijnen, Casper, et al.
Publicado: (2019)